VERSITI WISCONSIN INC

Versiti research advances scientific discovery and patient care through comprehensive support of blood-related research, education, and community engagement programs. Rooted in its nonprofit mission, versiti enables groundbreaking blood research while fostering the next generation of scientists and improving the lives of patients afflicted by blood disorders. In 2024, versiti researchers published 122 peer-reviewed manuscripts with 45 featuring vbri faculty as lead or senior authors, including 5 publications in journals with impact factors exceeding 30. 7 in journals with impact factors between 20 and 30, and 17 in journals with impact factors between 10 and 20. Versiti's research spans 5 major programs: transfusion medicine, vascular biology, and cellular therapy; thrombosis and (continued in schedule o) hemostasis; stem cell biology and hematopoiesis; immunology; and translational hematology. Versiti's research grant teams processed approximately $41m in new multi-year grants and submitted 112 proposals totaling $140.13m in 2024. Versiti also leads through collaborative blood science initiatives such as in venus (venous thromboembolism network us) and reds-iv-p (recipient epidemiology and donor evaluation study), national programs advancing thrombosis treatment and blood transfusion safety. Operating in an 82,000 square-foot facility, versiti is home to 213 research staff, including 35 investigators and 22 research scientists, in 2024. Educational initiatives include graduate training, research symposia, and collaborative partnerships in the milwaukee regional medical center, such as the mrmc hematology biorepository, which provides annotated biological samples for biomarker discovery for clinical partners throughout campus.

Msi:the versiti medical services institute (msi) advances patient care through specialized treatment and translational research that bridges clinical medicine and laboratory science, fostering collaboration between physician-scientists and basic researchers to accelerate medical discoveries. Established in 2009 and supported by versiti and the versiti blood research institute foundation, msi enables physicians to dedicate protected time to clinical research while maintaining patient care responsibilities. In 2024, versiti physician-scientists performed 3,686 therapeutic procedures. As part of versiti's mission to advance evidence-based medicine, msi operates the clinical trials & research office (ctro) to conduct fda-regulated clinical studies in specialized areas including alloimmune platelet disorders, transfusion-induced acute lung injury, and drug-induced blood disorders. Through mentorship, protected research time, and collaborative infrastructure, msi provides deep clinical expertise and transforms clinical questions into scientific discoveries that benefit patients with blood disorders nationwide.donor testing:the versiti donor testing laboratory (dtl) provides infectious disease testing to determine donor suitability and product safety for organs, tissues, hematopoietic stem cells, and cord blood. The dtl offers nucleic acid testing, antibody screening, and confirmatory testing for many different disease states. As part of versiti's mission to maintain the safest possible blood supply, donor testing operations conduct mandatory screening for transfusion-transmissible infections as required by fda regulations. The dtl utilizes state-of-the-art nucleic acid testing (nat) technology and serological methods to detect infectious agents. Versiti's dtl supports blood collection activities across versiti's entire geographic footprint while maintaining rigorous quality standards and regulatory compliance. Versiti's donor testing services strengthen the national blood supply infrastructure. By ensuring comprehensive donor screening, versiti protects patients who depend on safe blood transfusions, strengthens the national blood supply, and supports the broader public health mission of maintaining confidence in a high-quality blood supply.diagnostic labs:versiti serves patients, physicians, and hospitals by providing comprehensive clinical diagnostic testing services that support accurate diagnosis, treatment monitoring, and patient care across multiple medical specialties. As part of versiti's mission to advance healthcare through laboratory excellence, the diagnostic laboratories deliver specialized testing services including hematology, coagulation, immunohematology, infectious disease, molecular diagnostics, flow cytometry, and reference laboratory services. During 2024, versiti conducted 148,545 diagnostic testing services for hospitals, physician offices, and reference laboratories. Versiti's diagnostic laboratories maintain state-of-the-art instrumentation and rigorous quality assurance programs to ensure accurate, timely results that guide clinical decision-making and improve patient outcomes. The laboratories provide specialized expertise in blood-related disorders, offering advanced testing capabilities including platelet function analysis, coagulation studies, red blood cell antigen typing, and complex immunohematology workups that confirm and ensure transfusion safety. Versiti's diagnostic laboratories serve as a vital healthcare infrastructure resource, providing 24/7 testing support for emergency departments and critical care units. Through comprehensive diagnostic testing services, advanced laboratory expertise, and commitment to quality, versiti's diagnostic laboratories strengthen the healthcare system by enabling accurate diagnosis and optimal patient care across the state.organ and tissue:versiti organ and tissue operates as southeastern wisconsin's federally designated organ procurement organization, coordinating organ and tissue donation to save and heal lives throughout the state. Rooted in versiti's mission to advance public health, the organization facilitates the generous gift of donation by working with donor families, hospitals, and transplant centers to ensure organs and tissues reach patients in need. In 2024, versiti organ and tissue coordinated 394 organ transplants from 606 musculoskeletal donors. The organization provides 24/7 coordination services, family support, and clinical expertise throughout the donation process. Versiti's donation coordinators and clinical staff work alongside hospital teams to identify potential donors, support grieving families, and ensure optimal organ and tissue recovery. Through community education programs like donate life month in april, versiti promotes donation awareness and supports wisconsin families who choose the healing path of donation. By facilitating organ and tissue donation, versiti organ and tissue transforms tragedy into hope, enabling one donor to save up to eight lives through organ donation and heal dozens more through tissue donation.vcts:versiti clinical trials services (vcts) provides comprehensive clinical research services to pharmaceutical sponsors, biotechnology companies, and academic institutions conducting clinical studies in hematology, transfusion medicine, oncology, immunology, cell and gene therapy, and orphan and rare diseases. As part of versiti's mission to advance medical science, vcts offers specialized laboratory services, institutional review board (irb) oversight, biospecimen collection and management, project management, and regulatory support to ensure safe and compliant studies. Vcts leverages versiti's unique expertise in blood science and laboratory diagnostics to support complex trials requiring specialized testing capabilities. The program maintains rigorous quality standards and regulatory compliance while providing innovative solutions for complex clinical research challenges. Through expert clinical research services, versiti clinical trials accelerate the development of new treatments for blood disorders and support the advancement of evidence-based medicine in hematology and transfusion medicine.